Welcome to the e-CCO Library!

P771: Diagnostic performance of low haemoglobin density (LHD%) for detecting iron deficiency in patients with inflammatory bowel disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

K. Farrag1,2*, K. Ademaj1,2, E. Leventi1,2, A. Aksan2,3, J. Stein1,2

Created: Thursday, 21 February 2019, 9:14 AM
P771: Predictors of health-related quality of life in patients with moderate to severely active ulcerative colitis receiving biological therapy
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

B. Rasmussen*1, P. Haastrup1, S. Wehberg1, J. Kjeldsen2,3, F. Boch Waldorff1

Created: Friday, 22 February 2019, 9:41 AM
P771: The recombinant NZ9000SHD-5 attenuates the inflammation and mucosal lesions in dextran sodium sulfate-induced colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Zeng L., Chen Y.

Created: Wednesday, 20 February 2019, 10:36 AM
P772 Trends and risk factors of elderly-onset Crohn’s disease: A nationwide cohort study in South Korea
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J.M. Moon1, E.A. Kang1, K. Han2, S.W. Hong1, H. Soh1, S. Park1, J. Lee1, H.J. Lee1, J.P. Im1, J.S. Kim1

Created: Thursday, 30 January 2020, 10:12 AM
P772: Association of histological remission with long-term clinical outcomes in patients with ulcerative colitis: a multi-national retrospective study with centralized histological assessment
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Jairath, V.(1,2)*;Armuzzi, A.(3,4);Pai, R.K.(5);Sun, D.(6);Li, Y.(7);Bassel, M.(8);Brett, N.R.(8);Bojic, D.(9);
Created: Friday, 14 July 2023, 11:12 AM
P772: Development and validation of tools to assess food additive intake: the ENIGMA study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

G. Trakman*1,2, W. Y. Y. Lin3, A. Wilson-O'brien1,2, J. Ching3,4, W. Tang3,4, L. Orr3,4, A. Stanley2, A. L. Hamilton1,2, M. Morrison5, J. Yu3,4, J. J. Sung3,4, S. C. Ng3,4,6, M. A. Kamm1,2

Created: Friday, 22 February 2019, 9:41 AM
P772: Factors influencing adherence to oral 5-aminosalicylic acid in patients with ulcerative colitis
Year: 2018
Source: ECCO '18 Vienna
Authors:

S.M. Lee1*, T.O. Kim2, J. Lee2, H.W. Kim3, S.R. Ji4

Created: Thursday, 21 February 2019, 9:14 AM
P772: The presence of adherent-invasive Escherichia coli strains on the surgical specimen is a predictor of severe endoscopic postoperative recurrence in Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Barnich N.*1, Buisson A.2, Auzolle C.3, Rodrigues M.2, Stefanescu C.3, Nancey S.4, Desreumaux P.5, Marteau P.3, Fumery M.6, Sokol H.3, Treton X.3, Seksik P.3, Allez M.3

Created: Wednesday, 20 February 2019, 10:36 AM
P773 Patient reported outcomes, partial MAYO score and SCCAI are equally accurate in predicting mucosal healing in UC: Preliminary results from a prospective study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

P. Golovics1, L. Gonczi2, J. Reinglass3, C. Verdon3, W. Afif3, G. Wild3, A. Bitton3, E. Seidman3, T. Bessissow3, P.L. Lakatos PhD2,3

Created: Thursday, 30 January 2020, 10:12 AM
P773: Extended induction in the True North open-label extension study: clinical outcomes of ~2 years of ozanimod treatment
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Vermeire, S.(1)*;Colombel, J.F.(2);Chiorean, M.V.(3);Ghosh, S.(4);Jain, A.(5);Lawlor, G.(5);Osterman, M.T.(5);Wu, H.(5);Canavan, J.B.(5);Rubin, D.T.(6);
Created: Friday, 14 July 2023, 11:12 AM
P773: Post-operative Crohn's disease recurrence is associated with specific changes in the faecal microbiome – potential pathogenic and protective roles
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Hamilton A.L.*1,2, Kamm M.A.1,2, Teo S.-M.3, De Cruz P.1,2,4, Wright E.K.5, Feng H.6,7, Ritchie K.J.2, Kirkwood C.D.6, Inouye M.3

Created: Wednesday, 20 February 2019, 10:36 AM
P773: Rescue treatment with tacrolimus in patients with severe inflammatory bowel disease (IBD) without response to intensification of biological therapy
Year: 2018
Source: ECCO '18 Vienna
Authors:

L. Sanchis*, X. Cortés, J. Clofent, J. Rodriguez, J.R. Molés, S. Fernández, J. Borrás

Created: Thursday, 21 February 2019, 9:14 AM
P773: Sarcopenia is a new risk factor of non-alcoholic fatty liver disease in patients with inflammatory bowel disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

B. I. Jang*1, K. O. Kim1,2, C. H. Yang3

Created: Friday, 22 February 2019, 9:41 AM
P774 Low adhesion to latent tuberculosis (TB) screening recommendations in inflammatory bowel disease (IBD) patients: Results of the INFEII registry of GETECCU
Year: 2020
Source:

ECCO'20 Vienna

Authors:

Y. Zabana Abdo1,2, R. de Francisco3, I. Rodríguez-Lago4, M. Chaparro2,5,6, F. Gomollón2,7,8, M. Piqueras9, J. Llaó10, B. Sicilia11, E. Domènech2,12, O. García-Bosch13, L. de Castro14, X. Calvet2,15,16, V. Morales17, M. Rivero18, A.J. Lucendo2,6,19, P. Navarro20, L. Márquez21,22, D. Busquets23, J. Guardiola24,25, J. Gordillo26, E. Iglesias27, B. Beltrán2,28, E. Sesé29, R. Ferreiro-Iglesias30, M. Francisco31, R. Pajares32, A. Algaba33,34, R. Vicente35, O. Benítez1, M. Aceituno1,2, S. Riestra3, A. Rodríguez-Pescador4, J.P. Gisbert2,5,6, M.T. Arroyo7,8, R. Mena9, E. Sáinz10, L. Arias-García11, M. Mañosa2,12, M. Navarro13, L. Sanromán14, A. Villória2,15,16, P. Delgado-Villena17, M.J. García18, T. Angueira19, M. Mínguez20, F. Murciano21,22, C. Arajol24, M. Esteve1,2, Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU)

Created: Thursday, 30 January 2020, 10:12 AM
P774: Comparison of disease burden of ulcerative colitis patients treated with biologics/biosimilars in remission and not in remission across the EU5
Year: 2018
Source: ECCO '18 Vienna
Authors:

Y. Lu1*, A. Baskett2, H. Triggs2, B. Haven2, P. Collins2

Created: Thursday, 21 February 2019, 9:14 AM
P774: Higher plasma cotinine is associated with an increased risk for later developing IBD, especially among users of combusted tobacco
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

L. Widbom*1, J. Schneede2, P. Karling3, J. Hultdin1

Created: Friday, 22 February 2019, 9:41 AM
P774: Maintenance treatment with vedolizumab in children with Inflammatory Bowel Disease: follow-up results from the prospective multicenter VEDOKIDS study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Atia, O.(1); Shavit-Brunschwig, Z.(1);Quteineh, A.(1); Lev-Tzion, R.(1); Stein, R.(2);Broide, E.(3);Urlep, D.(4);Hyams, J.(5);Aloi, M.(6);Shouval, D.S.(7);Assa, A.(1);Hussey, S.(8);Markowitz, J.(9);Yerushalmy, A.(10);Miele, E.(11);Russell, R.K.(12);Turner, D.(1)*;
Created: Friday, 14 July 2023, 11:12 AM
P774: Metagenomics and metabolomics of patients with inflammatory bowel disease and their unaffected relatives
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Vancamelbeke M.*1, Sabino J.1, Deroover L.1, Vandermeulen G.1, Luypaerts A.1, Ferrante M.1,2, Falony G.3, Vieira-Silva S.3, Verbeke K.1, Raes J.3, Cleynen I.4, Vermeire S.1,2

Created: Wednesday, 20 February 2019, 10:36 AM
P775 Evolution of inflammatory bowel disease research from a bird’s eye perspective: A text-mining analysis of publication trends and topics
Year: 2020
Source:

ECCO'20 Vienna

Authors:

Y. Barash1, E. Klan1, N. Tau1, S. Ben-Horin1, A. Levartovsky1, N. Arebi2, S. Soffer1, U. Kopylov1

Created: Thursday, 30 January 2020, 10:12 AM
P775: Disease activity and treatment patterns of newly diagnosed adult patients with Crohn's disease in Japan: Interim analysis of inception cohort registry study of patients with Crohn's disease (iCREST-CD)
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Shinzaki, S.(1)*;Matsuoka, K.(2);Fujii, T.(3);Okamoto, R.(3);Yamada, A.(2);Kunisaki, R.(4);Matsuura, M.(5);Watanabe, K.(1);Shiga, H.(6);Takatsu, N.(7);Bamba, S.(8);Mikami, Y.(9);Yamamoto, T.(10);Shimoyama, T.(10);Motoya, S.(11);Torisu, T.(12);Kobayashi, T.(13);Ohmiya, N.(14);Saruta, M.(15);Matsuda, K.(16);Matsumoto, T.(17);Nakase, H.(18);Maemoto, A.(19);Murata, Y.(20);Yoshigoe, S.(20);Tsuchiya, H.(20);Hisamatsu, T.(5);
Created: Friday, 14 July 2023, 11:12 AM